| Literature DB >> 34068296 |
Juan-José Zamora-Sánchez1,2, Edurne Zabaleta-Del-Olmo1,3,4,5, Sergio Fernández-Bertolín3,4, Vicente Gea-Caballero6,7, Iván Julián-Rochina8, Gemma Pérez-Tortajada9, Jordi Amblàs-Novellas10.
Abstract
BACKGROUND: The multidimensional assessment of frailty allows stratifying it into degrees; however, there is still heterogeneity in the characteristics of people in each stratum. The aim of this study was to identify frailty profiles of older people users of a home-based primary care service.Entities:
Keywords: care dependence; cluster analysis; frailty; home care; multimorbidity; primary health care
Year: 2021 PMID: 34068296 PMCID: PMC8153285 DOI: 10.3390/jcm10102106
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Characteristics of participants in each of the six profiles identified through cluster analysis. Values are absolute frequencies (percentages) unless stated otherwise.
| Variables | Total | Profile 1 | Profile 2 | Profile 3 | Profile 4 | Profile 5 | Profile 6 | ||
|---|---|---|---|---|---|---|---|---|---|
| Age | Years, mean (SD) | 88.0 (8.1) | 87.7 (0.7) | 83.8 (6.8) | 86.1 (0.8) | 92.7 (0.6) | 87.9 (0.9) | 84.4 (1.7) | <0.001 |
| Sex | Men | 130 (31.6) | 25 (23.6) | 2 (50.0) | 44 (43.6) | 14 (15.2) | 35 (53.8) | 10 (22.7) | <0.001 |
| Women | 282 (68.4) | 81 (76.4) | 2 (50.0) | 57 (56.4) | 78 (84.8) | 30 (46.2) | 34 (77.3) | ||
| Chronic Diseases | Cancer (active) | 40 (9.7) | 4 (3.8) | 4 (100.0) | 10 (9.9) | 9 (9.8) | 12 (18.5) | 1 (2.3) | 0.009 |
| Respiratory | 116 (28.2) | 29 (27.4) | 3 (75.0) | 48 (47.5) | 7 (7.6) | 20 (30.8) | 9 (20.5) | <0.001 | |
| Cardiac | 248 (60.2) | 59 (55.7) | 0 (0.0) | 85 (84.2) | 37 (40.2) | 51 (78.5) | 16 (36.4) | <0.001 | |
| Neurological | 151 (36.7) | 17 (16.0) | 1 (25.0) | 48 (47.5) | 22 (23.9) | 40 (61.5) | 23 (52.3) | <0.001 | |
| Digestive | 39 (9.5) | 16 (15.1) | 0 (0) | 7 (6.9) | 6 (6.5) | 6 (9.2) | 4 (9.1) | 0.234 | |
| Renal (GFR < 60) | 206 (50.0) | 56 (52.8) | 1 (25.0) | 56 (55.4) | 57 (62.0) | 28 (43.1) | 8 (18.2) | <0.001 | |
| ≥3 target organ diseases | 129 (31.3) | 30 (28.3) | 1 (25.0) | 51 (50.5) | 15 (16.3) | 30 (46.2) | 2 (4.5) | <0.001 | |
| Advanced Chronic Disease | 32 (7.8) | 3 (2.8) | 4 (100) | 18 (17.8) | 1 (1.1) | 5 (7.7) | 1 (2.3) | <0.001 | |
| Severe Symptoms | Pain | 87 (21.1) | 26 (24.5) | 1 (25.0) | 34 (33.7) | 20 (21.7) | 6 (9.2) | 0 (0.0) | <0.001 |
| Dyspnea | 19 (4.6) | 4 (3.8) | 0 (0.0) | 14 (13.9) | 0 (0.0) | 0 (0.0) | 1 (2.3) | NA | |
| Geriatric syndromes | Delirium | 119 (28.9) | 4 (3.8) | 1 (25.0) | 6 (5.9) | 43 (46.7) | 37 (56.9) | 28 (63.6) | <0.001 |
| Falls | 112 (27.2) | 27 (25.5) | 1 (25.0) | 21 (20.8) | 33 (35.9) | 24 (36.9) | 6 (13.6) | 0.012 | |
| Ulcers | 85 (20.6) | 10 (9.4) | 2 (50.0) | 13 (12.9) | 21 (22.8) | 24 (36.9) | 15 (34.1) | <0.001 | |
| Dysphagia | 75 (18.2) | 0 (0.0) | 1 (25.0) | 11 (10.9) | 1 (1.1) | 29 (44.6) | 33 (75.0) | <0.001 | |
| Incontinence | 295 (71.6) | 45 (42.5) | 4 (100) | 70 (69.3) | 79 (85.9) | 54 (83.1) | 43 (97.7) | <0.001 | |
| Polypharmacy (≥5 drugs) | 365 (88.6) | 92 (86.8) | 4 (100.0) | 100 (99.0) | 74 (80.4) | 60 (92.3) | 35 (79.5) | <0.001 | |
| ≥3 geriatric syndromes | 87 (21.1) | 3 (2.8) | 1 (25.0) | 6 (5.9) | 20 (21.7) | 33 (50.8) | 24 (54.5) | <0.001 | |
| Malnutrition | Weight loss | 70 (17.0) | 18 (17.0) | 2 (50.0) | 11 (10.9) | 10 (10.9) | 22 (33.8) | 7 (15.9) | 0.001 |
| Cognitive impairment | Cognitive impairment | 214 (51.9) | 13 (12.3) | 1 (25.0) | 24 (23.8) | 77 (83.7) | 58 (89.2) | 41 (93.2) | <0.001 |
| Pfeiffer (Range 0–10), mean (SD) | 3.76 (3.33) | 1.15 (0.15) | 2.75 (1.80) | 1.94 (0.20) | 4.93 (0.23) | 5.84 (0.36) | 8.86 (0.39) | <0.001 | |
| Emotional Status | Treatment for depression | 158 (38.3) | 34 (32.1) | 2 (50.0) | 48 (47.5) | 35 (38.0) | 20 (30.8) | 19 (43.2) | 0.117 |
| Treatment for anxiety/insomnia | 226 (54.9) | 53 (50.0) | 1 (25.0) | 74 (73.3) | 45 (48.9) | 25 (38.5) | 28 (63.6) | <0.001 | |
| Social Vulnerability | Presence of social vulnerability | 212 (51.5) | 83 (78.3) | 1 (25.0) | 44 (43.6) | 36 (39.1) | 35 (53.8) | 13 (29.5) | <0.001 |
| Living alone | 70 (17.0) | 43 (40.6) | 0 (0.0) | 15 (14.9) | 6 (6.5) | 5 (7.7) | 1 (2.3) | <0.001 | |
| Professional caregiver 24 h a day | 97 (23.5) | 11 (10.4) | 0 (0.0) | 27 (26.7) | 27 (29.3) | 18 (27.7) | 14 (31.8) | 0.005 | |
| Basic Activities of Daily Living | Barthel Index, mean (SD) | 48.4 (26.9) | 73.0 (1.4) | 35.0 (5.4) | 51.1(1.7) | 51.4 (1.8) | 28.2 (3.3) | 7.9 (2.1) | <0.001 |
| BI ≥ 95 No dependency | 6 (1.5) | 4 (3.8) | 0 (0.0) | 0 (0.0) | 1 (1.1) | 1 (1.5) | 0 (0.0) | <0.001 (**) | |
| BI 90–65 (Mild–moderate) | 143 (34.7) | 85 (80.2) | 0 (0.0) | 26 (25.7) | 22 (23.9) | 9 (13.8) | 1 (2.3) | ||
| BI 60–25 (Moderate–severe) | 175 (42.5) | 16 (15.1) | 4 (100.0) | 71 (70.3) | 67 (72.8) | 15 (23.1) | 2 (4.5) | ||
| BI ≤ 20 Absolute dependency | 88 (21.4) | 1 (0.9) | 0 (0.0) | 4 (4.0) | 2 (2.2) | 40 (61.5) | 41 (93.2) | ||
| Instrumental Activities of | Money management | 350 (85.0) | 50 (47.2) | 3 (75.0) | 97 (96.0) | 91 (98.9) | 65 (100.0) | 44 (100.0) | <0.001 |
| Telephone use | 132 (32.0) | 0 (0.0) | 0 (0.0) | 10 (9.9) | 26 (28.3) | 52 (80.0) | 44 (100.0) | <0.001 | |
| Medication management | 304 (73.8) | 19 (17.9) | 2 (50.0) | 85 (84.2) | 89 (96.7) | 65 (100.0) | 44 (100.0) | <0.001 | |
| Frailty Frail-VIG index (FI) Range 0–1 | Frail VIG index, mean (SD) | 0.40 (0.12) | 0.28 (0.01) | 0.44 (0.02) | 0.41 (0.01) | 0.39 (0.01) | 0.52 (0.01) | 0.53 (0.01) | <0.001 |
| Non frailty (FI <0.20) | 12 (2.9) | 12 (11.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | <0.001 (***) | |
| Mild frailty (FI 0.20–0.35) | 116 (28.2) | 68 (64.2) | 0 (0.0) | 23 (22.8) | 24 (26.1) | 1 (1.5) | 0 (0.0) | ||
| Moderate frailty (FI 0.36–0.50) | 191 (46.4) | 26 (24.5) | 4 (100) | 63 (62.4) | 58 (63.0) | 28 (43.1) | 12 (27.3) | ||
| Severe frailty (FI >0.50) | 93 (22.6) | 0 (0.0) | 0 (0.0) | 15 (14.9) | 10 (10.9) | 36 (55.4) | 32 (72.7) | ||
| Quality of life | EQ-5D-3L Index. (Range 0–1) | 0.30 (0.23) | 0.44 (0.18) | 0.29 (0.16) | 0.29 (0.21) | 0.31 (0.24) | 0.19 (0.24) | 0.08 (0.01) | <0.001 |
| Mortality | Mortality of 12 months | 128 (31.1) | 14 (13.2) | 4 (100.0) | 30 (29.7) | 27 (29.3) | 34 (52.3) | 19 (43.2) | <0.001 |
| Mortality of 24 months | 190 (46.1) | 31 (29.2) | 4 (100.0) | 44 (43.6) | 40 (43.5) | 45 (69.2) | 26 (59.1) | <0.001 | |
(*) Profile 2 (4 cases) has been excluded in all p-value analyzes, in order to adjust to the application requirements of the tests. (**) The values of the Barthel index have been grouped into three levels (BI ≥ 95; BI 90–25; BI ≤ 20), to adapt the criteria for applying the chi-square test. (***) The frail-VIG index values have been grouped into three degrees of frailty (FI ≤ 0.35; FI 0.36–0.50; FI > 0.50) to adapt the criteria for applying the chi-square test. NA. The p-value calculation requirements do not apply. Abbreviations: BI, Barthel Index; FI, Frail-VIG Index; GFR, Glomerular Filtration Rate; SD, Standard Deviation.
Summary of the variables used to define each of the six frailty profiles in the cluster analysis.
| Profiles Domains | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Degree of frailty | Mild frailty | Moderate frailty | Moderate frailty | Moderate frailty | Severe frailty | Severe frailty |
| Age (years) | 87.7 | 83.8 | 86.1 | 92.7 | 87.9 | 84.4 |
| Women (%) | 76.4 | 50 | 56.4 | 84.8 | 46.1 | 77.3 |
| Chronic diseases | 2 | 3.6 | 3.2 | 1.7 | 2.6 | 1.4 |
| Physical frailty (0–4) (malnutrition, falls, ulcers, dysphagia) | 0.6 | 1.6 | 0.5 | 0.7 | 1.5 | 1.4 |
| Psychological frailty (0–5) | 0.9 | 1.6 | 1.5 | 2.3 | 2.2 | 3.4 |
| Social Frailty (0–1) | 0.8 | 0.3 | 0.4 | 0.4 | 0.5 | 0.3 |
| Functional dependence | 1.8 | 3.3 | 3.7 | 4 | 5.2 | 5.9 |
| Frail-VIG index (0–1) | 0.28 | 0.44 | 0.41 | 0.39 | 0.52 | 0.53 |
The profiles are ordered according to the similarity between them. The darker the color, the higher frequencies or values of the variables. Frail-VIG index, higher scores represent a higher degree of frailty. Abbreviations: ADLs, Activities of Daily Living; IADLs, Instrumental Activities of Daily Living.
Proposal for care objectives and interventions for each six profiles identified.
| Profiles | Profile 1 | Profile 2 | Profile 3 | Profile 4 | Profile 5 | Profile 6 |
|---|---|---|---|---|---|---|
| Objectives and Activities |
|
|
|
|
|
|
| Priority Objective | A–B | C | B–A | B–A | C–B | C–B |
| (A) Survival | ||||||
| (B) Preserve and enhance autonomy | ||||||
| (C) Wellbeing and symptom control | ||||||
| Physical activity planning | Group | Individual | Group | Group | Individual | Individual |
| activity | personalised | activity | activity | personalised | personalised | |
| according to comorbidity | ||||||
| Promote self-care | ++ | + | +++ | ++ | − | − |
| Maintenance of autonomy | +++ | ++ | +++ | +++ | + | + |
| Technical help/home adaptations | + | ++ | + | + | ++ | ++ |
| Diet, and nutritional supplements | Healthy diet Nutritional | Diet | Healthy diet | Healthy diet/on demand | ||
| supplements | on demand | Nutritional supplement | Nutritional supplement | |||
| adapted to comorbidity | adapted to comorbidity | |||||
| Prevention and management of dysphagia | + | ++ | + | + | ++ | +++ |
| Cognitive stimulation | + | − | + | ++ | ++ | − |
| Psychological intervention (Depression/Anxiety) | ++ | +++ | +++ | ++ | ++ | − |
| Prevention and management of delirium | − | + | + | ++ | ++ | +++ |
| Therapeutic adequacy and deprescription | + | +++ | + | ++ | +++ | +++ |
| Social intervention | +++ | +++ | + | + | ++ | ++ |
| Palliative needs care | + | ++++ | + | + | +++ | +++ |
| Advance care planning | + | ++++ | ++ | ++ | +++ | +++ |
| Caregiver support | + | +++ | ++ | ++ | +++ | +++ |
| Grief management in the patient’s family environment | + | ++++ | ++ | ++ | +++ | +++ |
Degree of intensity of the proposed interventions: minimum intensity (−), mild intensity (+), moderate intensity (++), high intensity (+++), very high intensity (++++).